Benjamin Edwards Inc’s Intellia Therapeutics NTLA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$591K Buy
63,034
+1,126
+2% +$10.6K 0.01% 799
2025
Q1
$440K Sell
61,908
-2,157
-3% -$15.3K 0.01% 826
2024
Q4
$747K Buy
64,065
+6,396
+11% +$74.6K 0.01% 706
2024
Q3
$1.18M Buy
57,669
+57,253
+13,763% +$1.18M 0.02% 551
2024
Q2
$9K Sell
416
-146
-26% -$3.16K ﹤0.01% 624
2024
Q1
$15K Buy
562
+35
+7% +$934 ﹤0.01% 605
2023
Q4
$16K Sell
527
-317
-38% -$9.62K ﹤0.01% 555
2023
Q3
$27K Buy
844
+78
+10% +$2.5K 0.01% 517
2023
Q2
$31K Buy
766
+18
+2% +$728 0.01% 507
2023
Q1
$28K Buy
748
+38
+5% +$1.42K 0.01% 512
2022
Q4
$25K Buy
710
+141
+25% +$4.97K 0.01% 482
2022
Q3
$32K Sell
569
-44
-7% -$2.48K 0.01% 454
2022
Q2
$32K Buy
613
+6
+1% +$313 0.01% 471
2022
Q1
$44K Sell
607
-81
-12% -$5.87K 0.01% 467
2021
Q4
$81K Buy
688
+36
+6% +$4.24K 0.03% 372
2021
Q3
$87K Sell
652
-198
-23% -$26.4K 0.05% 246
2021
Q2
$138K Sell
850
-443
-34% -$71.9K 0.09% 188
2021
Q1
$104K Sell
1,293
-8
-0.6% -$643 0.08% 198
2020
Q4
$71K Sell
1,301
-593
-31% -$32.4K 0.06% 216
2020
Q3
$38K Buy
1,894
+77
+4% +$1.55K 0.03% 242
2020
Q2
$38K Hold
1,817
0.03% 223
2020
Q1
$22K Sell
1,817
-61
-3% -$739 0.02% 234
2019
Q4
$28K Buy
1,878
+223
+13% +$3.33K 0.06% 150
2019
Q3
$22K Sell
1,655
-36
-2% -$479 0.05% 162
2019
Q2
$28K Buy
1,691
+640
+61% +$10.6K 0.07% 145
2019
Q1
$18K Buy
+1,051
New +$18K 0.09% 169